Shares of Haemonetics (NYSE: HAE) dipped sharply in mid-day trading following an intraday research note from an analyst at Natixis ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE